Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis

BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy is a promising treatment option for patients with refractory hematological malignancies. However, its efficacy in glioblastoma remains unclear. Here, we performed a systematic review to summarize the safety and efficacy of CAR T-cell therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Jong Keon, Pyo, Junhee, Suh, Chong Hyun, Park, Hye Sun, Chae, Young Kwang, Kim, Kyung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178287/
https://www.ncbi.nlm.nih.gov/pubmed/35692797
http://dx.doi.org/10.3389/fonc.2022.851877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178287/
https://www.ncbi.nlm.nih.gov/pubmed/35692797
http://dx.doi.org/10.3389/fonc.2022.851877

Ejemplares similares